Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes
| Image |  |
|---|---|
| Description | scientific article published on 01 October 2020 |
| Author/s |
author: Shivem B Shah |
| Publication date | October 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |